2 April 2021

Following recent FDA actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market.

On March 31, the FDA authorized several COVID-19 tests for over-the-counter (OTC) use without a prescription when used for serial screening (testing asymptomatic individuals multiple times on a routine basis), such as testing twice a week in schools or other settings.··(중략)

원문 바로보기 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-april-2-2021